Zentalis Pharmaceuticals IncNASDAQ:ZNTL
- LAST PRICE3.5700
- TODAY'S CHANGE (%)-0.6200 (-14.7971%)
- Bid / Lots3.5800/ 16
- Ask / Lots3.7500/ 5
- Open / Previous Close4.2200 / 4.1900
- Day Range
- 52 Week Range
- Volume1,301,250
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | ZNTL |
|---|---|---|
| 09:32 ET | 9761 | 4.11 |
| 09:34 ET | 300 | 4.13 |
| 09:36 ET | 721 | 4.13 |
| 09:38 ET | 240 | 4.15 |
| 09:39 ET | 200 | 4.13 |
| 09:41 ET | 250 | 4.11 |
| 09:43 ET | 351 | 4.11 |
| 09:45 ET | 1132 | 4.12 |
| 09:50 ET | 1702 | 4.08 |
| 09:52 ET | 500 | 4.08 |
| 09:54 ET | 633 | 4.095 |
| 09:56 ET | 600 | 4.11 |
| 09:57 ET | 1765 | 4.08 |
| 09:59 ET | 1193 | 4.04 |
| 10:01 ET | 2675 | 4.04 |
| 10:03 ET | 200 | 4.06 |
| 10:06 ET | 340 | 4.04 |
| 10:08 ET | 17113 | 4 |
| 10:10 ET | 3014 | 3.98 |
| 10:12 ET | 5168 | 3.96 |
| 10:14 ET | 14124 | 3.985 |
| 10:15 ET | 2962 | 3.94 |
| 10:17 ET | 1350 | 3.93 |
| 10:19 ET | 2511 | 3.94 |
| 10:21 ET | 3391 | 3.94 |
| 10:24 ET | 11061 | 3.92 |
| 10:26 ET | 8419 | 3.92 |
| 10:28 ET | 1234 | 3.9 |
| 10:30 ET | 5807 | 3.92 |
| 10:32 ET | 3153 | 3.93 |
| 10:33 ET | 28123 | 3.925 |
| 10:35 ET | 7692 | 3.9163 |
| 10:37 ET | 9382 | 3.9096 |
| 10:39 ET | 21184 | 3.8895 |
| 10:42 ET | 500 | 3.8893 |
| 10:44 ET | 2109 | 3.875 |
| 10:46 ET | 8059 | 3.84 |
| 10:48 ET | 1822 | 3.845 |
| 10:50 ET | 2068 | 3.85 |
| 10:51 ET | 4561 | 3.87 |
| 10:53 ET | 5643 | 3.86 |
| 10:55 ET | 16919 | 3.87 |
| 10:57 ET | 5217 | 3.8982 |
| 11:00 ET | 300 | 3.88 |
| 11:02 ET | 618 | 3.89 |
| 11:04 ET | 600 | 3.87 |
| 11:06 ET | 1355 | 3.87 |
| 11:08 ET | 2346 | 3.86 |
| 11:09 ET | 640 | 3.84 |
| 11:13 ET | 1287 | 3.85 |
| 11:15 ET | 10672 | 3.82 |
| 11:18 ET | 36017 | 3.8 |
| 11:20 ET | 3155 | 3.78 |
| 11:22 ET | 5422 | 3.77 |
| 11:24 ET | 22382 | 3.75 |
| 11:26 ET | 15022 | 3.7787 |
| 11:27 ET | 1165 | 3.77 |
| 11:29 ET | 624 | 3.7825 |
| 11:33 ET | 300 | 3.7701 |
| 11:36 ET | 1900 | 3.77 |
| 11:38 ET | 800 | 3.77 |
| 11:40 ET | 1010 | 3.765 |
| 11:42 ET | 2340 | 3.77 |
| 11:44 ET | 8568 | 3.79 |
| 11:45 ET | 200 | 3.78 |
| 11:47 ET | 1569 | 3.7895 |
| 11:49 ET | 200 | 3.78 |
| 11:51 ET | 1920 | 3.77 |
| 11:54 ET | 1000 | 3.77 |
| 11:56 ET | 6039 | 3.765 |
| 11:58 ET | 4700 | 3.745 |
| 12:00 ET | 925 | 3.735 |
| 12:02 ET | 10392 | 3.705 |
| 12:03 ET | 1250 | 3.6901 |
| 12:05 ET | 12300 | 3.6701 |
| 12:07 ET | 31725 | 3.69 |
| 12:09 ET | 9817 | 3.6601 |
| 12:12 ET | 4994 | 3.655 |
| 12:14 ET | 9203 | 3.655 |
| 12:16 ET | 1999 | 3.63 |
| 12:18 ET | 4885 | 3.6188 |
| 12:20 ET | 13782 | 3.58 |
| 12:21 ET | 16107 | 3.585 |
| 12:23 ET | 2250 | 3.58 |
| 12:25 ET | 5652 | 3.575 |
| 12:27 ET | 5024 | 3.575 |
| 12:30 ET | 37715 | 3.54 |
| 12:32 ET | 8456 | 3.545 |
| 12:34 ET | 5568 | 3.51 |
| 12:36 ET | 11471 | 3.49 |
| 12:38 ET | 2568 | 3.5 |
| 12:39 ET | 12513 | 3.47 |
| 12:41 ET | 3683 | 3.4699 |
| 12:43 ET | 2369 | 3.475 |
| 12:45 ET | 4048 | 3.47 |
| 12:48 ET | 4063 | 3.495 |
| 12:50 ET | 7037 | 3.5001 |
| 12:52 ET | 3410 | 3.48 |
| 12:54 ET | 769 | 3.4601 |
| 12:56 ET | 5822 | 3.45 |
| 12:57 ET | 2343 | 3.44 |
| 12:59 ET | 5092 | 3.46 |
| 01:01 ET | 300 | 3.4574 |
| 01:03 ET | 1600 | 3.455 |
| 01:06 ET | 14184 | 3.51 |
| 01:08 ET | 4798 | 3.555 |
| 01:10 ET | 3002 | 3.54 |
| 01:12 ET | 1100 | 3.535 |
| 01:14 ET | 5952 | 3.515 |
| 01:15 ET | 1700 | 3.515 |
| 01:17 ET | 532 | 3.51 |
| 01:19 ET | 7010 | 3.5012 |
| 01:21 ET | 5281 | 3.515 |
| 01:24 ET | 3356 | 3.5 |
| 01:26 ET | 4875 | 3.495 |
| 01:28 ET | 3383 | 3.47 |
| 01:30 ET | 500 | 3.4601 |
| 01:32 ET | 1047 | 3.4601 |
| 01:33 ET | 3815 | 3.46 |
| 01:35 ET | 3899 | 3.455 |
| 01:37 ET | 459 | 3.454 |
| 01:39 ET | 5422 | 3.48 |
| 01:42 ET | 3401 | 3.4768 |
| 01:44 ET | 1600 | 3.475 |
| 01:46 ET | 2981 | 3.4701 |
| 01:48 ET | 19228 | 3.5 |
| 01:50 ET | 1766 | 3.515 |
| 01:51 ET | 6662 | 3.51 |
| 01:53 ET | 350 | 3.5 |
| 01:55 ET | 1890 | 3.5 |
| 01:57 ET | 2500 | 3.5 |
| 02:00 ET | 628 | 3.52 |
| 02:02 ET | 7613 | 3.5399 |
| 02:04 ET | 1987 | 3.56 |
| 02:06 ET | 550 | 3.565 |
| 02:08 ET | 2693 | 3.565 |
| 02:09 ET | 240 | 3.57 |
| 02:11 ET | 100 | 3.565 |
| 02:13 ET | 1100 | 3.565 |
| 02:15 ET | 1100 | 3.57 |
| 02:18 ET | 5516 | 3.575 |
| 02:20 ET | 2441 | 3.57 |
| 02:22 ET | 2273 | 3.555 |
| 02:24 ET | 2700 | 3.555 |
| 02:26 ET | 1950 | 3.565 |
| 02:27 ET | 2800 | 3.575 |
| 02:29 ET | 11903 | 3.6 |
| 02:31 ET | 2030 | 3.61 |
| 02:33 ET | 17103 | 3.63 |
| 02:36 ET | 5295 | 3.6313 |
| 02:38 ET | 4109 | 3.635 |
| 02:40 ET | 15603 | 3.655 |
| 02:42 ET | 400 | 3.655 |
| 02:44 ET | 5737 | 3.635 |
| 02:45 ET | 800 | 3.635 |
| 02:47 ET | 700 | 3.635 |
| 02:49 ET | 8581 | 3.62 |
| 02:51 ET | 1550 | 3.605 |
| 02:54 ET | 4218 | 3.585 |
| 02:56 ET | 2525 | 3.58 |
| 02:58 ET | 4508 | 3.575 |
| 03:00 ET | 520 | 3.575 |
| 03:02 ET | 1128 | 3.57 |
| 03:03 ET | 7458 | 3.565 |
| 03:05 ET | 5517 | 3.575 |
| 03:07 ET | 3300 | 3.585 |
| 03:09 ET | 300 | 3.585 |
| 03:12 ET | 1510 | 3.57 |
| 03:14 ET | 28184 | 3.5999 |
| 03:16 ET | 8392 | 3.595 |
| 03:18 ET | 3040 | 3.6 |
| 03:20 ET | 1467 | 3.6 |
| 03:21 ET | 5060 | 3.605 |
| 03:23 ET | 15655 | 3.585 |
| 03:25 ET | 1350 | 3.585 |
| 03:27 ET | 100 | 3.585 |
| 03:30 ET | 862 | 3.58 |
| 03:32 ET | 1400 | 3.585 |
| 03:34 ET | 100 | 3.58 |
| 03:36 ET | 200 | 3.58 |
| 03:39 ET | 919 | 3.585 |
| 03:41 ET | 904 | 3.58 |
| 03:43 ET | 500 | 3.58 |
| 03:45 ET | 1674 | 3.58 |
| 03:48 ET | 35270 | 3.615 |
| 03:50 ET | 4595 | 3.61 |
| 03:52 ET | 26719 | 3.635 |
| 03:54 ET | 6157 | 3.63 |
| 03:56 ET | 20470 | 3.59 |
| 03:57 ET | 14577 | 3.585 |
| 03:59 ET | 20247 | 3.57 |
Today
Yesterday
Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4), from 6:00PM ET on Monday Jul 01, 2024 by Dow Jones
6:00PM ET on Monday Jul 01, 2024 by Dow Jones
Jun 30, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL, from 3:33PM ET on Sunday Jun 30, 2024 by Dow Jones
3:33PM ET on Sunday Jun 30, 2024 by Dow Jones
Jun 28, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL, from 10:18AM ET on Friday Jun 28, 2024 by Dow Jones
10:18AM ET on Friday Jun 28, 2024 by Dow Jones
Jun 26, 2024
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Zentalis Pharmaceuticals, Inc. - ZNTL, from 2:31PM ET on Wednesday Jun 26, 2024 by Dow Jones
2:31PM ET on Wednesday Jun 26, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Zentalis Pharmaceuticals Inc | 297.5M | -1.1x | --- |
Alto Neuroscience Inc | 306.5M | -5.9x | --- |
Nautilus Biotechnology Inc | 284.4M | -4.2x | --- |
Atea Pharmaceuticals Inc | 283.8M | -1.7x | --- |
ALX Oncology Holdings Inc | 312.1M | -1.5x | --- |
Korro Bio Inc | 313.9M | -0.8x | --- |
Company Information
Zentalis Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. The Company’s lead product candidate includes azenosertib (ZN-c3), which is a WEE1 inhibitor for advanced solid tumors and hematological malignancies. The Company is also developing a BCL-2 inhibitor, ZN-d5, for hematological malignancies and related disorders. ZN-d5 is being evaluated in combination with azenosertib in a Phase I/II dose escalation clinical trial in patients with R/R acute myeloid leukemia (AML) (ZN-d5-004C). The Company is also advancing its research on protein degraders and other undisclosed targets using its Integrated Discovery Engine.
Contact Information
- Headquarters
- 10275 Science Center Drive, Suite 200SAN DIEGO, CA, United States 92121
- Phone
- 858-263-4333
- Fax
- 302-655-5049
Executives
- Independent Chairman of the Board
- David Johnson
- President, Executive Director
- Cam Gallagher
- Chief Executive Officer, Director
- Kimberly Blackwell
- Chief Financial Officer, Treasurer
- Melissa Epperly
- Chief Operating Officer
- Iris Roth
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $297.5M |
|---|---|
Revenue (TTM) | $40.6M |
Shares Outstanding | 71.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.70 |
EPS | $-3.36 |
Book Value | $6.18 |
P/E Ratio | -1.1x |
Price/Sales (TTM) | 7.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -639.35% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
